Praxis stops pivotal trial of rare epilepsy drug early for efficacy
Praxis stops pivotal trial of rare epilepsy drug early for efficacy
Praxis stops pivotal trial of rare epilepsy drug early for efficacy
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.